Tumor biology correlates with rates of breastconserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial Academic Article uri icon

Overview

MeSH Major

  • Breast Neoplasms
  • Mastectomy, Segmental

abstract

  • Patients with triple-negative and HER2-positive breast cancers have the highest rates of breast-conserving surgery and pCR after neoadjuvant chemotherapy. Patients with these subtypes are most likely to be candidates for less invasive surgical approaches after chemotherapy.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4159769

Digital Object Identifier (DOI)

  • 10.1097/SLA.0000000000000924

PubMed ID

  • 25203877

Additional Document Info

start page

  • 608

end page

  • 14; discussion 614-6

volume

  • 260

number

  • 4